Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway.

IF 4.2 2区 医学 Q2 MICROBIOLOGY Antimicrobial Agents and Chemotherapy Pub Date : 2026-11-11 DOI:10.1128/aac.00963-26
Junbo Huang, Qing Song, Yanjun Di, Zhiyun Cheng, Haowei Lin, Haoyi Zhan, Yanhui Chen, Yachen Wang, Lijuan Xie, Fucai Wang, Lei Tong
{"title":"Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway.","authors":"Junbo Huang, Qing Song, Yanjun Di, Zhiyun Cheng, Haowei Lin, Haoyi Zhan, Yanhui Chen, Yachen Wang, Lijuan Xie, Fucai Wang, Lei Tong","doi":"10.1128/aac.00963-26","DOIUrl":null,"url":null,"abstract":"<p><p>Coxsackievirus B3 (CVB3) is the primary pathogen of viral myocarditis (VMC), and there is no specific therapy. Rosmarinic acid (RA) has anti-inflammatory and antioxidant properties, but its anti-CVB3 activity and mechanism remain unclear. This study examined the inhibitory effect of RA on CVB3 replication and VMC, and the underlying mechanism. In CVB3-infected HeLa cells and a mouse VMC model, RA blocked viral replication dose-dependently, with an EC50 of 26.49 μM and a selectivity index of 21.72, which was more effective than ribavirin. Time-of-addition experiments showed that RA interfered with the post-entry replication stage. Mechanistically, RA directly bound sirtuin 1 (SIRT1), with an affinity of -10.2 kcal/mol, increasing its conformational stability and inhibiting ubiquitin-proteasome degradation, thereby reversing CVB3-induced SIRT1 downregulation. Antiviral and anti-inflammatory effects of RA were abolished by SIRT1 knockdown. RA activated the AMPK/Nrf2/HO-1 cascade in a SIRT1-dependent manner. Notably, the HO-1 metabolite biliverdin (BV) stimulated STAT1/2 phosphorylation and interferon-stimulated gene expression. <i>In vivo</i>, RA effectively ameliorated CVB3-induced myocardial injury and restored SIRT1/AMPK/Nrf2/HO-1 expression. In conclusion, RA prevents CVB3 replication and VMC via direct binding and stabilization of SIRT1, activation of the SIRT1/AMPK/Nrf2/HO-1/BV signaling pathway, and stimulation of interferon response through STAT1/2.</p>","PeriodicalId":8152,"journal":{"name":"Antimicrobial Agents and Chemotherapy","volume":" ","pages":"e0096326"},"PeriodicalIF":4.2000,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Agents and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/aac.00963-26","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Coxsackievirus B3 (CVB3) is the primary pathogen of viral myocarditis (VMC), and there is no specific therapy. Rosmarinic acid (RA) has anti-inflammatory and antioxidant properties, but its anti-CVB3 activity and mechanism remain unclear. This study examined the inhibitory effect of RA on CVB3 replication and VMC, and the underlying mechanism. In CVB3-infected HeLa cells and a mouse VMC model, RA blocked viral replication dose-dependently, with an EC50 of 26.49 μM and a selectivity index of 21.72, which was more effective than ribavirin. Time-of-addition experiments showed that RA interfered with the post-entry replication stage. Mechanistically, RA directly bound sirtuin 1 (SIRT1), with an affinity of -10.2 kcal/mol, increasing its conformational stability and inhibiting ubiquitin-proteasome degradation, thereby reversing CVB3-induced SIRT1 downregulation. Antiviral and anti-inflammatory effects of RA were abolished by SIRT1 knockdown. RA activated the AMPK/Nrf2/HO-1 cascade in a SIRT1-dependent manner. Notably, the HO-1 metabolite biliverdin (BV) stimulated STAT1/2 phosphorylation and interferon-stimulated gene expression. In vivo, RA effectively ameliorated CVB3-induced myocardial injury and restored SIRT1/AMPK/Nrf2/HO-1 expression. In conclusion, RA prevents CVB3 replication and VMC via direct binding and stabilization of SIRT1, activation of the SIRT1/AMPK/Nrf2/HO-1/BV signaling pathway, and stimulation of interferon response through STAT1/2.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
迷迭香酸通过SIRT1/AMPKα/Nrf2途径诱导HO-1发挥抗cvb3作用。
柯萨奇病毒B3 (CVB3)是病毒性心肌炎(VMC)的主要病原体,目前尚无特异性治疗方法。迷迭香酸(RA)具有抗炎、抗氧化作用,但其抗cvb3活性及其机制尚不清楚。本研究探讨了RA对CVB3复制和VMC的抑制作用及其机制。在cvb3感染的HeLa细胞和小鼠VMC模型中,RA阻断病毒复制呈剂量依赖性,EC50为26.49 μM,选择性指数为21.72,优于利巴韦林。添加时间实验表明,RA干扰了进入后的复制阶段。在机制上,RA直接结合SIRT1 (SIRT1),其亲和力为-10.2 kcal/mol,增加了SIRT1的构象稳定性,抑制了泛素蛋白酶体的降解,从而逆转了cvb3诱导的SIRT1下调。SIRT1敲低可消除RA的抗病毒和抗炎作用。RA以sirt1依赖的方式激活AMPK/Nrf2/HO-1级联。值得注意的是,HO-1代谢产物胆绿素(BV)刺激STAT1/2磷酸化和干扰素刺激基因表达。在体内,RA可有效改善cvb3诱导的心肌损伤,恢复SIRT1/AMPK/Nrf2/HO-1的表达。综上所述,RA通过直接结合和稳定SIRT1、激活SIRT1/AMPK/Nrf2/HO-1/BV信号通路以及通过STAT1/2刺激干扰素反应来阻止CVB3复制和VMC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.00
自引率
8.20%
发文量
762
审稿时长
3 months
期刊介绍: Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
期刊最新文献
Inhibitors of monocarboxylate transporters as host-directed antivirals against human adenoviruses. Fosmanogepix-induced agranulocytosis. Rosmarinic acid exerts anti-CVB3 effects by inducing HO-1 via the SIRT1/AMPKα/Nrf2 pathway. In vitro activity of manogepix against Candida spp. displaying elevated echinocandin MIC results. Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis.
wanfang
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1